Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Strategies to manage retinoblastoma in developing countries.

Chantada GL, Qaddoumi I, Canturk S, Khetan V, Ma Z, Kimani K, Yeniad B, Sultan I, Sitorus RS, Tacyildiz N, Abramson DH.

Pediatr Blood Cancer. 2011 Mar;56(3):341-8. doi: 10.1002/pbc.22843. Epub 2010 Nov 11. Review.

PMID:
21225909
2.

Retinoblastoma: lessons and challenges from developing countries. Ellsworth Lecture 2011.

Chantada GL.

Ophthalmic Genet. 2011 Nov;32(4):196-203. doi: 10.3109/13816810.2011.592173. Epub 2011 Jul 19. Review.

PMID:
21770696
3.

Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.

Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M.

Br J Ophthalmol. 2009 Jan;93(1):28-32. doi: 10.1136/bjo.2008.139410. Epub 2008 Oct 24.

PMID:
18952647
4.

Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators.

Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, Sultan I, Kebudi R, Sharma T, Rodriguez-Galindo C, Abramson DH, Chantada GL.

Br J Ophthalmol. 2010 Nov;94(11):1432-6. doi: 10.1136/bjo.2009.168062. Epub 2010 Aug 23. Review.

PMID:
20733021
5.

The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.

Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S, Völker-Dieben HJ.

Ophthalmic Genet. 2009 Mar;30(1):31-6. doi: 10.1080/13816810802464320.

PMID:
19172508
6.

Familial retinoblastoma in developing countries.

Chantada GL, Dunkel IJ, Qaddoumi I, Antoneli CB, Totah A, Canturk S, Nawaiseh I, Fandiño A, Pífano I, Peksayar G, Ribeiro KB, Abramson DH.

Pediatr Blood Cancer. 2009 Sep;53(3):338-42. doi: 10.1002/pbc.21970.

PMID:
19434730
7.

Clinical presentation of retinoblastoma in a middle-income country.

Navo E, Teplisky D, Albero R, Fandino AC, Demirdjian G, Chantada GL.

J Pediatr Hematol Oncol. 2012 Apr;34(3):e97-101. doi: 10.1097/MPH.0b013e31821d18f9.

PMID:
22009008
8.

SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries.

Chantada G, Luna-Fineman S, Sitorus RS, Kruger M, Israels T, Leal-Leal C, Bakhshi S, Qaddoumi I, Abramson DH, Doz F; SIOP-PODC Graduated-Intensity Retinoblastoma Guidelines Writing Committee.

Pediatr Blood Cancer. 2013 May;60(5):719-27. doi: 10.1002/pbc.24468. Epub 2013 Jan 17.

PMID:
23335388
9.

[Childhood cancer: progress but prognosis still very unequal. Example of Retinoblastoma and high-risk Neuroblastoma].

Levy D, Aerts I, Michon J, Lumbroso-Le Rouic L, Cellier C, Orbach D.

Bull Cancer. 2014 Mar;101(3):250-7. doi: 10.1684/bdc.2014.1904. French.

PMID:
24691189
10.

Clinical characteristics and treatment outcome of children with intraocular retinoblastoma: a report from a Chinese cooperative group.

Gao YJ, Qian J, Yue H, Yuan YF, Xue K, Yao YQ.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1113-6. doi: 10.1002/pbc.23002. Epub 2011 Jun 16.

PMID:
21681922
11.

Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000.

Kao LY, Su WW, Lin YW.

Jpn J Ophthalmol. 2002 Sep-Oct;46(5):577-80.

PMID:
12457919
12.

Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation.

Temming P, Lohmann D, Bornfeld N, Sauerwein W, Goericke SL, Eggert A.

Klin Padiatr. 2012 Oct;224(6):339-47. doi: 10.1055/s-0032-1327563. Epub 2012 Nov 9. Review.

PMID:
23143761
13.

Causes, outcome and prevention of abandonment in retinoblastoma in India.

Kumar A, Moulik NR, Mishra RK, Kumar D.

Pediatr Blood Cancer. 2013 May;60(5):771-5. doi: 10.1002/pbc.24454. Epub 2013 Jan 9.

PMID:
23303533
14.

Metastatic retinoblastoma clinical features, treatment, and prognosis.

Gündüz K, Müftüoglu O, Günalp I, Unal E, Taçyildiz N.

Ophthalmology. 2006 Sep;113(9):1558-66. Epub 2006 Jul 7.

PMID:
16828510
15.

[Retinoblastoma in Kenya: survival and prognostic factors].

Gichigo EN, Kariuki-Wanyoike MM, Kimani K, Nentwich MM.

Ophthalmologe. 2015 Mar;112(3):255-60. doi: 10.1007/s00347-014-3123-z. German.

PMID:
25378130
16.

Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.

Ozdemir H, Tacyildiz N, Unal E, Yavuz G, Ugur H, Gunduz K.

Pediatr Hematol Oncol. 2007 Apr-May;24(3):221-31.

PMID:
17454793
17.

[The results of multimodal treatment in retinoblastoma].

Zemba M, Voinea S, Dragomir M, Blidaru A.

Oftalmologia. 1998;45(4):46-54. Romanian.

PMID:
10418627
18.

[Retinoblastoma].

Bornfeld N.

Klin Monbl Augenheilkd. 1999 Apr;214(4):aA10-1. German. No abstract available.

PMID:
10407797
19.

Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan.

Araki Y, Matsuyama Y, Kobayashi Y, Toyokawa S, Inoue K, Suzuki S, Makimoto A.

Jpn J Clin Oncol. 2011 Mar;41(3):373-9. doi: 10.1093/jjco/hyq201. Epub 2010 Nov 4.

PMID:
21051531
20.

Clinical presentation and survival of retinoblastoma in Indian children.

Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey RM.

Br J Ophthalmol. 2016 Feb;100(2):172-8. doi: 10.1136/bjophthalmol-2015-306672. Epub 2015 Jun 10.

PMID:
26061162

Supplemental Content

Support Center